Abstract
Although the risk of progression from monoclonal B-cell lymphocytosis (MBL) to chronic lymphocytic leukemia (CLL) has been well characterized, it is unknown whether other common complications associated with CLL, such as increased risk of infection, occurs in individuals with MBL. We used the Mayo CLL database to identify cohorts of individuals with newly diagnosed MBL (n=154) or newly diagnosed CLL (n=174) who resided within 50 miles of Mayo Clinic. A cohort of 689 adult patients seen for a general medical examination who resided within 50 miles of Mayo clinic and who enrolled in a case–control study of non-Hodgkin lymphoma (NHL) was used as a comparison cohort. Hospitalization with infection was more common among individuals with MBL (25/154; 16.2%), and CLL (32/174; 18.4%) than controls (18/689; 2.6%). On pooled multivariable Cox proportional hazards analysis of all 1017 patients (controls, MBL and CLL), male sex (hazards ratio (HR)=2.3; P=0.002), major co-morbid health problems (HR=1.7, P=0.04), the presence of CLL (HR=3.2, P<0.001), treatment for progressive CLL (HR=2.4, P=0.001) and the presence of MBL (HR=3.0, P=0.001) were independently associated with risk of hospitalization for infection. These results suggest the risk of serious infection in clinical MBL is substantially greater than the risk of progression requiring treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325–332.
Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. . Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010; 24: 512–520.
Rawstron A, Green M, Kuzmicki A, Kennedy B, Fenton J, Evans P et al. Monoclonal B lymphocytes with the characteristics of ‘indolent’ chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002; 100: 635–639.
Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004; 103: 2337–2342.
Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 2010; 78 (Suppl 1): S19–S23.
Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, Plummer M et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008; 359: 575–583.
Shanafelt T, Kay N, Rabe K, Call T, Zent CS, Maddocks K et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis (MBL) compared to patients with Rai 0 chronic lymphocytic leukemia (CLL). J Clin Oncol 2009; 27: 3959–3963.
Morrison VA . Management of infectious complications in patients with chronic lymphocytic leukemia. Hematol Am Soc Hematol Educ Program 2007; 2007: 332–338.
Francis S, Karanth M, Pratt G, Starczynski J, Hooper L, Fegan C et al. The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia. Cancer 2006; 107: 1023–1033.
Anderson LA, Landgren O, Engels EA . Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol 2009; 147: 444–449.
Landgren O, Rapkin JS, Caporaso NE, Mellemkjaer L, Gridley G, Goldin LR et al. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 2007; 109: 2198–2201.
Landgren O, Gridley G, Check D, Caporaso NE, Morris Brown L . Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol 2007; 139: 791–798.
Cerhan JR, Fredericksen ZS, Wang AH, Habermann TM, Kay NE, Macon WR et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet 2011; 2: 95–113.
Thurmes P, Call T, Slager S, Zent C, Jenkins G, Schwager S et al. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma 2008; 49: 49–56.
Bergstralh E, Offord K, Kosanke J, Augustine G . PERSONYRS: A SAS Procedure for Person-Years Analyses. SAS Institute Inc: Cary, NC, 1986.
Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009; 146: 64–75.
Wadhwa PD, Morrison VA . Infectious complications of chronic lymphocytic leukemia. Semin Oncol 2006; 33: 240–249.
Tsai HT, Caporaso NE, Kyle RA, Katzmann JA, Dispenzieri A, Hayes RB et al. Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood 2009; 114: 4928–4932.
Levi F, Randimbison L, Te VC, La Vecchia C . Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847–1850.
Travis LB, Curtis RE, Hankey BF, Fraumeni JF . Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992; 84: 1422–1427.
Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 2009; 27: 904–910.
Royle JA, Baade PD, Joske D, Girschik J, Fritschi L . Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer 2011; 105: 1076–1081.
Zent CS, Ding W, Reinalda MS, Schwager SM, Hoyer JD, Bowen DA et al. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. LeukLymphoma 2009; 50: 1261–1268.
Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009; 114: 33–37.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author contributions
JM and TDS designed research, performed research, analyzed/interpreted data and wrote the manuscript. KGR and SLS designed research, performed research, analyzed/interpreted data and reviewed/edited the manuscript. JRC, NEK, JWW, TGC, JFL, DFJ and DAB analyzed/interpreted data and reviewed/edited the manuscript. SMS performed research and reviewed/edited the manuscript. CAH performed research, analyzed/interpreted data and reviewed/edited the manuscript.
Rights and permissions
About this article
Cite this article
Moreira, J., Rabe, K., Cerhan, J. et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia 27, 136–141 (2013). https://doi.org/10.1038/leu.2012.187
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.187
Keywords
This article is cited by
-
Clonal haematopoiesis and dysregulation of the immune system
Nature Reviews Immunology (2023)
-
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis
Leukemia (2022)
-
The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
Blood Cancer Journal (2022)
-
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Leukemia (2022)
-
Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)
Leukemia (2021)